| SCRIP | BUY PRICE | MARKET PRICE | QUANTITY | BUY VALUE | MARKET VALUE | GAIN/LOSS | GAIN/LOSS % |
| AUROBINDO PHARMA | 152.3 | 306.2 | 3,877 | 590,467 | 1,187,137 | 596,670.30 | 101.1 |
| HINDALCO | 96.65 | 120.5 | 3,650 | 352,773 | 439,825 | 87,052.50 | 24.7 |
| CAIRN INDIA | 287.7 | 325 | 695 | 199,952 | 225,875 | 25,923.50 | 13 |
| INFINITE COMPUTER | 107.4 | 120.6 | 2,450 | 263,130 | 295,470 | 32,340.00 | 12.3 |
| SHREE CEMENT | 4,000.95 | 4,296.15 | 59 | 236,056 | 253,473 | 17,416.80 | 7.4 |
| GLENMARK PHARMA | 490 | 525.1 | 300 | 147,000 | 157,530 | 10,530.00 | 7.2 |
| CIPLA | 366.3 | 388.75 | 1,781 | 652,380 | 692,364 | 39,983.50 | 6.1 |
| AMBUJA CEMENT | 175.5 | 185.1 | 3,020 | 530,010 | 559,002 | 28,992.00 | 5.5 |
| ICICI BANK | 1,087.25 | 1,143.90 | 599 | 651,263 | 685,196 | 33,933.40 | 5.2 |
| HDFC BANK | 649.1 | 682.7 | 853 | 553,682 | 582,343 | 28,660.80 | 5.2 |
| NMDC LTD | 138.75 | 142.95 | 530 | 73,538 | 75,764 | 2,226.00 | 3 |
| LIQUID BENCHMARK MF | 1,000.00 | 1,000.00 | 387 | 387,000 | 387,000 | 0 | 0 |
| E.I.D. PARRY Results | 150.5 | 139.75 | 2,833 | 426,367 | 395,912 | -30,454.80 | -7.1 |
| GRAND TOTAL | 5,063,617 | 5,936,890 | 873,274.00 | 17.2 |
The portfolio was created post budget and it has outperformed the market by 10% although Nifty is not the benchmark the portfolio was tracking. Aurobindo Pharma being the leader in terms of performance, but even other stocks have performed very well.
My contrarian approach of entering the stocks at low levels has helped in generating the alpha. Going further with the same approach i will be bullish in consumption, pharma and also take some positions in PSUs. All of the sectors entered will have different time horizons ranging from 3 months to 3 years.
No comments:
Post a Comment